Login to Your Account



Pharma: Clinic Roundup


Monday, September 16, 2013

• Forest Laboratories Inc., of New York, received Qualified Infectious Disease Product designation from the FDA for ceftazidime/avibactam.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription